Beijing Hemu Biotechnology Co., Ltd. announced that it will receive CNY 15,500,000 in an equity round of funding on December 14, 2022. The transaction will include participation form new investor, Tianjin Yiyi Hygiene Products Co.,Ltd for CNY 6,700,000, and China-US Green Huitong (Tianjin) Venture Capital Fund Partnership (Limited Partnership) for CNY 5,000,000, and new individual investors, Gao Fuzhong for CNY 2,200,000 and Lu Junmei for CNY 1,100,000, and returning individual investor, Nie Shucheng for CNY 500,000. Post the closing of the transaction, the registered capital of the company holds by Tianjin Yiyi Hygiene Products Co.,Ltd for CNY 620,376 accounting for 8.8742% stake , China-US Green Huitong (Tianjin) Venture Capital Fund Partnership (Limited Partnership) for CNY 462,967 accounting for 6.6225% stake, Gao Fuzhong for CNY 203,705 accounting for 2.9139% stake, Lu Junmei for CNY 101,853 accounting for 1.457% stake, and Nie Shucheng for CNY 115,746 accounting for 1.6557% stake.

The funds raised through non-public issuance of shares, of which CNY 1,435,197 is included in the registered capital and CNY 14,064,803 in included in the capital reserve. The transaction was approved by the fifth meeting of the third board of directors and the fifth meeting of the third board of supervisors of the investors. The transaction of capital increase does not need to be submitted to the general meeting of shareholders for consideration.